Urinary zinc excretion and zinc status of patients with β-thalassemia major

Biological Trace Element Research

Volumn 70, Issue 2, 1999, Pages 165-172

  Aydinok, Y ^a   Coker, C ^a   Kavakli, K ^a   Polat, A ^a   Nisli, G ^a   Cetiner, N ^a   Kantar, M ^a   Cetingul N ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Desferrioxamine; Renal tubular dysfunction; Thalassemia major; Zinc

Indexed keywords

CREATININE; DEFEROXAMINE; ZINC;

ADOLESCENT; ADULT; ARTICLE; ATOMIC EMISSION SPECTROMETRY; BETA THALASSEMIA; CHILD; CLINICAL ARTICLE; COMORBIDITY; CREATININE URINE LEVEL; FEMALE; HUMAN; KIDNEY TUBULE DISORDER; MALE; URINARY EXCRETION; ZINC BLOOD LEVEL; ZINC URINE LEVEL;

EID: 0032759637     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02783857     Document Type: Article

References (17)

1. J. P. Van Woue, Clinical and laboratory assessment of zinc deficiency in Dutch children, Biol. Trace Element Res. 49, 211-225 (1995).
2. B. Melichar, P. Jandik, F. Malir, J. Vavrova, J. Bures, J. Merpancova, Z. Vaboril, Association between renal tubular cell dysfunction and increased urinary zinc excretion in cancer patients, Scand. J. Clin. Lab. Invest. 55, 149-152 (1995).
3. U. Dogru, A. Arcasoy, and A. O. Cavdar, Zinc levels of plasma, erythrocyte, hair and urine in homozygote beta thalassemia, Acta Haematol. 62, 41-44 (1979).
4. D. S. Virgilis, M. Congia, F. Frau, F. Arpiolu, G. Diana, F. Cucca, et al., Desferrioxamine induced growth retardation in patients with thalassemia major, J. Pediatr. 113, 661-669 (1988).
5. Z. Uysal, N. Akar, S. Kemahli, N. Dincer, A. Arcasoy, Desferrioxamine and urinary zinc excretion in β-thalassemia major, Pediatr. Hematol. Oncol. 10, 257-260 (1993).
6. N. Al-Refaie, B. Wonke, D. G. Wickens, Y. Aydinok, A. Fielding, A. V. Hoffbrand, Zinc concentration in patients with iron overload receiving oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one or desferrioxamine, J. Clin. Pathol. 47, 657-660 (1994).
7. E. Nixon, T. P. Mayer, P. Johnson, J. T. McCall, A. B. Ness, W. H. Fjersted and M. B. Wehde, Routine measurement of calcium, magnesium, copper, zinc and iron in urine and serum by inductively coupled plasma emission spectroscopy, Clin. Chem. 32(9), 1660-1665 (1986).
8. D. J. Mahler, J. R. Walsh, and G. D. Haynie, Magnesium, zinc and copper in dialysis patients, Am. J. Clin. Pathol. 56, 17-23 (1971).
9. J. C. Moore and J. E. Moris, A simple automated calorimetric method for determination of N-acetyl - D-glucosaminidase, Ann. Clin. Biochem. 19, 157-159 (1982).
10. B. L. Vallee and K. H. Falchuk, The biochemical basis of zinc physiology, Physiol. Rev. 73, 79-118 (1993).
11. S. K. Mahajan, Zinc in kidney disease, J. Am. Coll. Nutr. 8, 296-304 (1989).
12. D. J. Weatherall, Pathophysiology of thalassaemia, in Baillière's Clinical Haematology, Volume 11(1), G. P. Rodgers, ed., Baillière Tindall, pp. 127-146 (1998).
13. G. J. Fuchs, P. Tienboon, S. Linpisarn, S. Nimsakul, P. Leelapat, S. Tovanabutra, et al., Nutritional factors and thalassaemia major, Arch. Dis. Child. 74, 224-227 (1996).
14. A. Silprasert, T. Laokuldilok, and P. Kulapongs, Zinc deficiency in β-thalassemic children, in Thalassemia: Pathophysiology and Management, part A. S. Fucharoen, P. T. Rowley, and N. W. Paul, eds., Alan R. Liss, New York (1998).
15. M. J. Pippard, M. J. Jackson, K. Hoffman, M, Petrou, C. B. Modell, Iron chelation using subcutaneous infusions of diethylene triamine penta-acetic acid (DTPA), Scand. J. Haematol. 36, 466-472 (1986).
16. A. Sumboonnanonda, P. Malasit, S. Voravam, S. Ong-ajyooth, S. Sunthornchart, S.Pattanakitsakul, et al., Renal tubular function in β-thalassemia, Pediatr. Nephrol. 12, 280-283 (1998).
17. P. Cianciulli, D. Sollecito, F. Sorrentino, L. Forte, E. Gilardi, A. Massa, et al., Early detection of nephrotoxic effects in thalassemic patients receiving desferrioxamine therapy, Kidney Int. 46, 467-470 (1994).